FerroBio Technologies Joins 2025 Biotherapies Pavilion

AABB is pleased to welcome FerroBio Technologies to the Biotherapies Pavilion at the 2025 AABB Annual Meeting, taking place Oct. 25-28 in San Diego. FerroBio is an emerging company focused on advancing research by providing research-use-only cell isolations. The company specializes in isolating CD34+ cells from donated cord blood.

FerroBio will be among several innovative companies participating in this year’s pavilion, a dedicated networking space in the Exhibit Hall presented by Abbott. The Biotherapies Pavilion offers biotherapies organizations curated opportunities to connect with key audiences and engage with the broader AABB Annual Meeting community.

Additional participants at this year’s pavilion include BBG Advanced Therapies, Charles River Laboratories, Eurofins CellTx, Versiti and Vitalant.

The Biotherapies Pavilion at the 2025 AABB Annual Meeting will once again feature industry expert open-mic conversations, a highlight from the 2023 and 2024 meetings. AABB will announce the schedule for this year's sessions and events in September.

Biotherapies companies interested in securing a networking table or connection package at this year’s pavilion can find additional details in the Biotherapies Pavilion brochure.